ArticleEmerging infectious diseases2016
Elevated Risk for Antimicrobial Drug-Resistant Shigella Infection among Men Who Have Sex with Men, United States, 2011-2015.
Article in Emerging infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.
- Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2021Guideline
- Isolation and characterization of lyticFrontiers in cellular and infection microbiology · 2026Article
- Safety and Tolerability of ShigActive™, aAntibiotics (Basel, Switzerland) · 2024Article
- Healthcare providers' knowledge and clinical practice surrounding shigellosis - DocStyles Survey, 2020.BMC primary care · 2023Article
- Discovery of a novel sub-lineage of multi-drug resistant Shigella flexneri in Southern California.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023Article
- Further characterization ofFrontiers in immunology · 2023Article
- Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017-2020.Emerging infectious diseases · 2022Review
- Virulence plasmid pINV as a genetic signature forMicrobial genomics · 2022Article
- Decreased Susceptibility ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2022Article
- Evaluation of whole-genome sequencing-based subtyping methods for the surveillance ofMicrobial genomics · 2021Article
- Prevalence of Gastrointestinal Pathogens Detected by Multiplex Polymerase Chain Reaction in a Prospective Cohort of Men Who Have Sex With Men Taking Human Immunodeficiency Virus Preexposure Prophylaxis-New York City, 2019-2020.Open forum infectious diseases · 2021Article
- Article
- Genomic Drivers of Multidrug-ResistantmBio · 2021Article
- Brazilian Protocol for Sexually Transmitted Infections, 2020: sexually transmitted enteric infections.Revista da Sociedade Brasileira de Medicina Tropical · 2021Article
- International Spread of Multidrug-Resistant Campylobacter coli in Men Who Have Sex With Men in Washington State and Québec, 2015-2018.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
- Gastroenteritis in Men Who Have Sex With Men in Seattle, Washington, 2017-2018.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
- Decreased Susceptibility to Azithromycin in Clinical Shigella Isolates Associated with HIV and Sexually Transmitted Bacterial Diseases, Minnesota, USA, 2012-2015.Emerging infectious diseases · 2020Article
- Persistent Transmission of Shigellosis in England Is Associated with a Recently Emerged Multidrug-Resistant Strain of Shigella sonnei.Journal of clinical microbiology · 2020Article
- A Multifactorial Approach for Surveillance ofFrontiers in microbiology · 2020Article
- Critical Role for the NLRP3 Inflammasome in Mediating IL-1β Production inFrontiers in immunology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shigella spp. cause ≈500,000 illnesses in the United States annually, and resistance to ciprofloxacin, ceftriaxone, and azithromycin is emerging. We investigated associations between transmission route and antimicrobial resistance among US shigellosis clusters reported during 2011-2015. Of 32 clusters, 9 were caused by shigellae resistant to ciprofloxacin (3 clusters), ceftriaxone (2 clusters), or azithromycin (7 clusters); 3 clusters were resistant to >1 of these drugs. We observed resistance to any of these drugs in all 7 clusters among men who have sex with men (MSM) but in only 2 of the other 25 clusters (p<0.001). Azithromycin resistance was more common among MSM-associated clusters than other clusters (86% vs. 4% of clusters; p<0.001). For adults with suspected shigellosis, clinicians should culture feces; obtain sex histories; discuss shigellosis prevention; and choose treatment, when needed, according to antimicrobial drug susceptibility. Public health interviews for enteric illnesses should encompass sex practices; health messaging for MSM must include shigellosis prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.